Catalyst Wire Dossier Catalyst Wire Dossier

ATZUMI

DIHYDROERGOTAMINE MESYLATE · Satsuma Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ATZUMI, covering 2025-04-30 to 2025-04-30. Get the full timeline:

Most recent: FDA Approved: ATZUMI — Original Application (Satsuma Pharmaceuticals, Inc.)

See pricing